Excision Repair Cross-complementation Group 1 is a Prognostic Biomarker in Patients with Colorectal Cancer Receiving Chemotherapy.

Abstract

BACKGROUND Conflicting results about the association between expression level of excision repair cross-complementation group 1 (ERCC1) and clinical outcome in patients with colorectal cancer (CRC) receiving chemotherapy have been reported. Thus, we searched the available articles and performed the meta-analysis to elucidate the prognostic role of ERCC1… (More)
DOI: 10.4103/0366-6999.176993

Topics

Cite this paper

@article{Li2016ExcisionRC, title={Excision Repair Cross-complementation Group 1 is a Prognostic Biomarker in Patients with Colorectal Cancer Receiving Chemotherapy.}, author={Mu-xing Li and Xin-yu Bi and Hong Zhao and Zhen Huang and Yue Han and Dong-bin Zhao and Jian-jun Zhao and Jian-qiang Cai}, journal={Chinese medical journal}, year={2016}, volume={129 5}, pages={586-93} }